Table 4:

Bivariate Analysis of Factors Associated with Initiation of Hepatitis C Antiviral Treatment among 165 Patients with Chronic Hepatitis C in an Emergency Department-Based HCV Linkage to Care Program

Characteristics	Category	Total No.	No. of Initiating Treatment (%)	Odds Ratio (95% CI)
Age	Increasing each year	165	84 (51)	1.04 (1.01, 1.08)*
Birth Cohort	Baby Boomer	119	63 (53)	1.34 (0.68, 2.65)
	Non-Baby Boomer	46	21 (46)	1.00
Sex	Male	109	56 (51)	1.06 (0.56, 2.01)
	Female	56	28 (50)	1.00
Race	African American	138	72 (52)	1.36 (0.60, 3.13)
	Other	27	12 (44)	1.00
Health Insurance	Public - Medicaid	86	45 (52)	1.44 (0.62, 3.32)
	Public - Medicare	49	26 (53)	1.48 (0.59, 3.69)
	Private and Self-Pay	30	13 (43)	1.00
Having a PCP	Yes	137	76 (55)	3.12 (1.28, 7.56)*
	No	28	8 (29)	1.00
Injection Drug Use	Ever	90	43 (48)	0.76 (0.41, 1.40)
	Never	75	41 (55)	1.00
Liver Fibrosis†	Advanced (F3 or higher)	69	40 (58)	1.63 (0.87, 3.04)
	Non-Advanced or Unknown	96	44 (46)	1.00

^*p<0.05

^†Liver fibrosis staging determined by the serology test (FibroSURE) or transient elastography (FibroScan) results

PCP: Primary Care Physician